4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-031262
President and CEO gave up 5,584 shares (to pay taxes)
- President and CEO acquired 14,612 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2023-05-18 | Option exercise | +6,758 | 7,671,197 | D | ||
| Jiang Wenbin President and CEO | 2023-05-18 | Shares withheld for taxes | −2,633 | $6.69 | $17,615 | 7,668,564 | D |
| Jiang Wenbin President and CEO | 2023-05-18 | Option exercise | +7,854 | 7,676,418 | D | ||
| Jiang Wenbin President and CEO | 2023-05-18 | Shares withheld for taxes | −2,951 | $6.69 | $19,742 | 7,673,467 | D |
| Derivatives | |||||||
| Jiang Wenbin President and CEO | 2023-05-18 | Option exercise · Restricted Stock Units | −6,758 | 72,094 | D | ||
| Jiang Wenbin President and CEO | 2023-05-18 | Option exercise · Restricted Stock Units | −7,854 | 180,647 | D | ||
Loading xslF345X04/doc4.xml…